At ECTRIMS 2025, the interim chief executive officer at the Consortium of Multiple Sclerosis Centers discussed recent progress in multiple sclerosis for treatment and diagnosis. [WATCH TIME: 5 minutes]
Kathleen Costello, CRNP, MSCN
Advertisement
Interim chief executive officer of the Consortium of Multiple Sclerosis Centers.
Articles by Kathleen Costello, CRNP, MSCN
IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).
Kathleen Costello discusses her new role as interim CEO of the CMSC. She has the support of Jeff Wilken, CMSC president, and Tina Trott, CMSC director.
The interim chief executive officer at the Consortium of Multiple Sclerosis Centers invites healthcare professionals to the Consortium ’s annual meeting from May 28–31 in Phoenix, Arizona. [WATCH TIME: 2 minutes]
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
2
Expanding Patient Expectations When Managing Generalized Myasthenia Gravis: A Treating Physician’s Experience with IMAAVY™ (nipocalimab-aahu)
3
Apomorphine Sublingual Film Displays Efficacy in Elderly Patients with Parkinson Disease
4
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
5
